A. Janu

发表

Percutaneous CT Guided Vertebral Biopsy: Anatomy and Technical Considerations

Nitin R Shetty, K. Gala, N. Shetty, 2021, Journal of Clinical Interventional Radiology ISVIR.

A. Janu, A. Patra, A. Sahu, 2019, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.

CT-guided radiofrequency ablation in osteoid osteoma: Result from a tertiary cancer centre in India

A. Puri, V. Rangarajan, A. Gulia, 2017, Indian Journal of Radiology and Imaging.

ALK1 Gene Rearranged Pulmonary Sarcomatoid Carcinoma Masquerading as Tuberculosis in a Young Male

Rajiv Kumar, K. Prabhash, A. Janu, 2021, Turk patoloji dergisi.

Carcinoma Cuniculatum of the Oral Cavity: A Series of 6 Cases and Review of Literature

S. Rane, A. Patil, A. Janu, 2021, Head and Neck Pathology.

The efficacy and safety of first-line therapy for the epidermal growth factor receptor mutant non-small cell lung cancer in older versus younger patients: A pooled analysis of two randomized controlled trials

Rajiv Kumar, A. Mahajan, K. Prabhash, 2020, Cancer Research, Statistics, and Treatment.

Oral metronomic chemotherapy after definitive chemoradiation in esophageal squamous cell carcinoma: a randomized clinical trial

A. Mahajan, N. Mummudi, K. Prabhash, 2022, Esophagus.

Combined Motor Evoked Potential Monitoring and Subcortical Dynamic Mapping in Motor Eloquent Tumors Allows Safer and Extended Resections.

A. Moiyadi, V. Madhugiri, K. Seidel, 2018, World neurosurgery.

Prognostic Impact of Semantic MRI Features on Survival Outcomes in Medulloblastoma: Does It Reflect or Transcend Radiogenomic Correlation?

A. Chatterjee, T. Gupta, S. Pungavkar, 2021 .

Clinical approach to re-irradiation for recurrent diffuse intrinsic pontine glioma.

A. Chatterjee, T. Gupta, R. Jalali, 2021, Japanese journal of clinical oncology.

Maintenance pemetrexed in nonsmall cell lung carcinoma: Outcome analysis from a tertiary care center

A. Mahajan, K. Prabhash, V. Noronha, 2015, Indian Journal of Medical and Paediatric Oncology.

Efficacy of Second-Line Pemetrexed-Carboplatin in EGFR-Activating Mutation-Positive NSCLC: Does Exon 19 Deletion Differ from Exon 21 Mutation?

Rajiv Kumar, A. Mahajan, A. Bhattacharjee, 2017, Chemotherapy research and practice.

EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?

Rajiv Kumar, A. Mahajan, K. Prabhash, 2016, OncoTargets and therapy.

Third-line therapy in the epidermal growth factor receptor mutation-positive advanced nonsmall-cell lung cancer

A. Mahajan, K. Prabhash, V. Noronha, 2020, South Asian Journal of Cancer.

Real-World Experience of Patients with Inoperable, Stage III Non-small-Cell Lung Cancer Treated with Durvalumab after Chemoradiotherapy: Indian Experience

A. Mahajan, K. Prabhash, V. Noronha, 2020, South Asian journal of cancer.

The Importance of Brain Metastasis in EGFR Mutation Positive NSCLC Patients

K. Prabhash, V. Noronha, V. Patil, 2014, Chemotherapy research and practice.

Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer.

A. Dutt, Rajiv Kumar, A. Mahajan, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Concomitant use of antibiotics and immune checkpoint inhibitors in patients with solid neoplasms: retrospective data from real-world settings

A. Mahajan, K. Prabhash, V. Noronha, 2020, Ecancermedicalscience.

Unilateral Interstitial Lung Disease with Contralateral Effusion: Unusual Case Report of Dasatinib Toxicity

A. Janu, S. Tandon, P. Biraris, 2022, Indian Journal of Medical and Paediatric Oncology.

Characteristics and clinical outcomes of pulmonary sarcomatoid carcinoma: experience from Tata Memorial Centre

K. Prabhash, V. Noronha, V. Patil, 2022, ecancermedicalscience.

Oral metronomic chemotherapy after definitive chemoradiation in esophageal squamous cell carcinoma: a randomized clinical trial

A. Mahajan, N. Mummudi, K. Prabhash, 2022, Esophagus.

Safety and efficacy of bevacizumab biosimilar in recurrent/ progressive glioblastoma

A. Mahajan, A. Chatterjee, T. Gupta, 2021, Ecancermedicalscience.

Percutaneous Radiofrequency Ablation of Appendicular Skeleton Chondroblastoma-an Experience from a Tertiary Care Cancer Center.

A. Puri, M. Shariq, A. Gulia, 2021, Journal of vascular and interventional radiology : JVIR.

Proposed sub-compartmentalization of high infratemporal fossa involvement in gingivobuccal cancers and its impact on clinical outcome and staging: A narrative review

A. Mahajan, S. Rane, K. Prabhash, 2022, Cancer Research, Statistics, and Treatment.

Outcomes of osteosarcoma, chondrosarcoma and chordoma treated with image guided-intensity modulated radiation therapy.

A. Puri, P. Pai, D. Nair, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

MB-36COMBINED CLINICAL PARAMETERS WITH SPECIFIC MRI FEATURES YIELD HIGHLY ACCURATE PREDICTION OF MEDULLOBLASTOMA SUBTYPES: DATA FROM 72 PATIENTS IN A BLINDED STUDY

A. Mahajan, T. Gupta, A. Moiyadi, 2016 .

Outcomes with Palliative Weekly Paclitaxel in Advanced, Recurrent, and Metastatic Esophageal Cancer - Real World Experience

A. Mahajan, K. Prabhash, V. Noronha, 2018, Indian Journal of Medical and Paediatric Oncology.

Small cell carcinoma of the oesophagus: experience of an Indian Tertiary Cancer Centre

A. Mahajan, K. Prabhash, V. Noronha, 2022, ecancermedicalscience.

Small Cell Carcinoma Esophagus: Experience of an Indian Tertiary Cancer Center

Rajiv Kumar, A. Mahajan, K. Prabhash, 2021 .

Epidemiological Trend of Esophageal Cancer at a Tertiary Cancer Center in Mumbai, India, Over the Past 15 Years

R. Dikshit, A. Mahajan, K. Prabhash, 2022, Journal of Gastrointestinal Cancer.

ALK-positive advanced non-small cell lung cancer patients with poor performance status: Outcomes in a real-world scenario

A. Mahajan, K. Prabhash, V. Noronha, 2022, Ecancermedicalscience.

Case Series of Applications of Resting State Functional MRI in Brain Tumor Surgery: A Novel Technique

P. Shetty, A. Janu, A. Sahu, 2021, Indian Journal of Radiology and Imaging.

Delftia acidovorans: An unusual pathogen from an adenocarcinoma lung patient with pleural effusion

V. Bhat, A. Janu, S. Biswas, 2022, Journal of Global Infectious Diseases.

Primary mediastinal germ cell tumours with high prevalence of somatic malignancy: An experience from a single tertiary care oncology centre.

Rajiv Kumar, C. Pramesh, K. Prabhash, 2021, Annals of diagnostic pathology.

Prognostic impact of semantic MRI features on survival outcomes in molecularly subtyped medulloblastoma

A. Chatterjee, T. Gupta, R. Jalali, 2022, Strahlentherapie und Onkologie.

EGFR exon 20 insertion in non-small cell lung cancer

A. Mahajan, K. Prabhash, V. Noronha, 2022, Cancer Research, Statistics, and Treatment.

Nomograms based on preoperative multiparametric magnetic resonance imaging for prediction of molecular subgrouping in medulloblastoma: results from a radiogenomics study of 111 patients

S. Kannan, A. Mahajan, T. Gupta, 2018, Neuro-oncology.

Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung Cancer

S. Kannan, A. Mahajan, A. Bhattacharjee, 2019, EClinicalMedicine.

Impact of exon 19 versus exon 21 EGFR-activating mutation on outcomes with upfront pemetrexed–carboplatin chemotherapy

Rajiv Kumar, A. Mahajan, A. Bhattacharjee, 2017, Ecancermedicalscience.

Cortical Destruction / Cortical Thickening Soft Tissue Infiltration MRI Findings Differential Diagnosis

A. Gulia, A. Janu, S. Juvekar, 2016 .

ALK Positive Lung Cancer: Clinical Profile, Practice and Outcomes in a Developing Country

Abhishek Mahajan, Amit Janu, Vipul Doshi, 2016, PloS one.

Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study

A. Mahajan, A. Bhattacharjee, K. Prabhash, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ROS1 mutation non-small cell lung cancer—access to optimal treatment and outcomes

Rajiv Kumar, A. Mahajan, K. Prabhash, 2019, ecancermedicalscience.

Randomized phase 3 open label study of quality of life of patients on Pemetrexed versus Erlotinib as maintenance therapy for advanced non squamous non EGFR mutated non small cell lung cancer

Rajiv Kumar, A. Mahajan, A. Bhattacharjee, 2019, Oncotarget.

The role of chemotherapy in patients with small cell lung cancer and poor performance status

A. Mahajan, K. Prabhash, V. Noronha, 2020, Acta oncologica.

Protocol for a phase II randomised controlled trial of TKI alone versus TKI and local consolidative radiation therapy in patients with oncogene driver-mutated oligometastatic non-small cell lung cancer

N. Mummudi, K. Prabhash, J. Agarwal, 2021, BMJ Open.

Quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of a Phase III randomized trial to compare the benefit of gefitinib versus pemetrexed/carboplatin for epidermal growth factor receptor-mutated non-small cell lung cancer

A. Mahajan, A. Bhattacharjee, K. Prabhash, 2019, Cancer Research, Statistics, and Treatment.

Tyrosine Kinase Inhibitor versus Physician Choice Chemotherapy in Second-Line Epidermal Growth Factor Receptor Mutation Non-Small Cell Lung Cancer: Post hoc Analysis of Randomized Control Trial

Rajiv Kumar, A. Mahajan, A. Bhattacharjee, 2018, Indian Journal of Medical and Paediatric Oncology.

Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma

Rajiv Kumar, A. Mahajan, A. Bhattacharjee, 2017, ESMO Open.

Standard maintenance therapy versus local consolidative radiation therapy and standard maintenance therapy in 1–5 sites of oligometastatic non-small cell lung cancer: a study protocol of phase III randomised controlled trial

N. Mummudi, K. Prabhash, J. Agarwal, 2021, BMJ Open.

Prognostic Impact of Baseline Liver Metastasis in ALK Fusion-Positive Metastatic Lung Cancer: A Retrospective Review

Rajiv Kumar, A. Mahajan, K. Prabhash, 2022, South Asian Journal of Cancer.

Adapting Management of Sarcomas in COVID-19: An Evidence-Based Review

N. Salins, A. Gulia, S. Bakhshi, 2020, Indian Journal of Orthopaedics.

Demographics, Pattern of Care, and Outcome Analysis of Malignant Melanomas - Experience From a Tertiary Cancer Centre in India

Rajiv Kumar, K. Prabhash, Sudeep Gupta, 2021, Frontiers in Oncology.

Approach to imaging of lesions of Jaw

A. Janu, S. Shukla, Shubham Padashetty, 2022, IP Indian Journal of Anatomy and Surgery of Head, Neck and Brain.

Leptomeningeal metastasis from non-small cell lung cancer— a post-hoc analysis from four randomised clinical trials

A. Mahajan, K. Prabhash, V. Noronha, 2022, Ecancermedicalscience.

Reverse swing‐M, phase 1 study of repurposing mebendazole in recurrent high‐grade glioma

A. Mahajan, A. Bhattacharjee, T. Gupta, 2020, Cancer medicine.

Radiotherapy Dose Escalation in Unresectable Ewing's Sarcoma: Final Results of a Phase III Randomized Controlled Trial.

A. Puri, S. Sinha, V. Rangarajan, 2022, International journal of radiation oncology, biology, physics.

Crizotinib-Associated Renal Cysts: A Case Series

A. Baheti, A. Janu, A. Patra, 2019, Journal of Gastrointestinal and Abdominal Radiology.

A prospective study to evaluate the use of surveillance venous ultrasonography to detect incidence of deep venous thrombosis following neurosurgical excision of brain tumors

A. Janu, A. Moiyadi, S. Parab, 2023, Journal of neurosciences in rural practice.

Analysis of bone and soft-tissue sarcomas registered during the year 2012 at Tata Memorial Hospital, Mumbai, with clinical outcomes.

A. Puri, V. Rangarajan, N. Purandare, 2018, Indian Journal of Cancer.

Malignant giant solitary fibrous tumour of the mediastinum; masquerading Triton tumour

A. Janu, Arshi Beg, R. Kaushal, 2021, Surgical and Experimental Pathology.

Imaging Recommendations for Diagnosis, Staging and Management of Larynx and Hypopharynx Cancer

A. Bhalla, A. Mahajan, S. Sinha, 2023, Indian Journal of Medical and Paediatric Oncology.

Practice Patterns and Outcomes for Pemetrexed Plus Platinum Doublet as Neoadjuvant Chemotherapy in Adenocarcinomas of Lung: Looking Beyond the Usual Paradigm.

A. Mahajan, K. Prabhash, J. Agarwal, 2018, Clinics in oncology.

A real‐world data of Immune checkpoint inhibitors in solid tumors from India

A. Mahajan, K. Prabhash, V. Noronha, 2021, Cancer medicine.

1049P Efficacy and safety of low dose immunotherapy in palliative setting of advanced solid tumours

A. Mahajan, K. Prabhash, V. Noronha, 2020 .

Clinico-radiological characteristics, histo-pathological features and long-term survival outcomes in central neurocytoma: A single-institutional audit

A. Chatterjee, T. Gupta, P. Shetty, 2020, Journal of Clinical Neuroscience.

Unusual Presentation of Gout as Giant Cell Tumor of Bone: A Case Report

A. Puri, A. Gulia, A. Janu, 2020, Journal of orthopaedic case reports.

Systemic inflammatory biomarkers in primary central nervous system lymphoma versus high-grade glioma: exploratory, comparative and correlative analysis

T. Gupta, V. Rangarajan, N. Purandare, 2022, CNS oncology.

The complementary role of MRI and FET PET in high grade gliomas to differentiate recurrence from radionecrosis

A. Mahajan, T. Gupta, V. Rangarajan, 2023, Frontiers in Nuclear Medicine.

DEV-19. THE ROLE OF COMBAT (COMBINED ORAL METRONOMIC BIODIFFERENTIATING ANTIANGIOGENIC TREATMENT) IN HIGH-RISK AND RELAPSED MEDULLOBLASTOMA: A SINGLE INSTITUTION EXPERIENCE

V. Bhat, T. Gupta, H. Sankaran, 2018, Neuro-Oncology.

Second opinion interpretations by specialty radiologists in head-and-neck oncology and their impact on clinical management: A retrospective observational study

A. Mahajan, K. Prabhash, R. Vaish, 2022, Cancer Research, Statistics, and Treatment.

Unusual sites of metastases at initial presentation in Ewing-like sarcoma of extremity in an elderly male

A. Janu, A. Choudhari, P. Nandakumar, 2022, Annals of Oncology Research and Therapy.

A not-always-benign pleural tumor

A. Janu, Nivedita Chakrabarty, Ujjwal Agarwal, 2023, Cancer Research, Statistics, and Treatment.

Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation?

Rajiv Kumar, A. Mahajan, A. Bhattacharjee, 2018, Lung India : official organ of Indian Chest Society.

Phase III randomized trial comparing gefitinib to gefitinib with pemetrexed-carboplatin chemotherapy in patients with advanced untreated EGFR mutant non-small cell lung cancer (gef vs gef+C).

A. Dutt, Rajiv Kumar, A. Mahajan, 2019, Journal of Clinical Oncology.

Phosphaturic Mesenchymal Tumors from Head to Toe: Imaging Findings and Role of the Radiologist in Diagnosing Tumor-Induced Osteomalacia

A. Puri, A. Kawthalkar, A. Gulia, 2020, Indian Journal of Orthopaedics.

Leptomeningeal metastases: can MRI compare with CSF analysis

M. Thakur, A. Moiyadi, A. Janu, 2015 .

Institutional Patterns of Care of Diffuse Intrinsic Pontine Glioma

T. Gupta, R. Jalali, Pallavi P Rane, 2023, Neurology India.

ROS1 rearranged nonsmall cell lung cancer and crizotinib: An Indian experience.

A. Mahajan, K. Prabhash, V. Noronha, 2017, Indian Journal of Cancer.

Utility of flouro-deoxy-glucose positron emission tomography/computed tomography in the diagnostic and staging evaluation of patients with primary CNS lymphoma

S. Kannan, A. Mahajan, T. Gupta, 2019, CNS oncology.

Clinical Profile, Practice Pattern, and Outcomes With First-Line Therapy in ALK-Positive Lung Cancer: Real-World Data From Resource-Constrained Settings

Rajiv Kumar, A. Mahajan, K. Prabhash, 2022, JTO clinical and research reports.

Impact of sex of the patient on efficacy and safety of cancer immunotherapy: A retrospective audit

A. Mahajan, K. Prabhash, V. Noronha, 2021 .

Long-Term Outcomes of Crizotinib Treated ALK-Positive Lung Cancer Patients: A Retrospective Audit of Prospective Data from Resource-Constrained Settings

Rajiv Kumar, A. Mahajan, K. Prabhash, 2022, South Asian Journal of Cancer.

Deep learning based automated epidermal growth factor receptor and anaplastic lymphoma kinase status prediction of brain metastasis in non-small cell lung cancer

A. Mahajan, N. Mummudi, K. Prabhash, 2023, Exploration of targeted anti-tumor therapy.

Ceritinib in anaplastic lymphoma kinase-positive nonsmall cell lung cancer among patients who were previously exposed to crizotinib: Experience from the Indian subcontinent.

A. Mahajan, K. Prabhash, V. Noronha, 2017, Indian journal of cancer.

Primary Intracranial Germ Cell Tumors: A Study with an Integrated Clinicopathological Approach.

T. Gupta, P. Shetty, G. Chinnaswamy, 2023, Neurology India.

Outcomes based on histological tumor necrosis and predictive clinical and laboratory parameters for necrosis in children with osteosarcoma treated on a non-High Dose Methotrexate based chemotherapy backbone

N. Purandare, B. Rekhi, A. Gulia, 2022 .

SALTT study: A retrospective analysis of 111 SAlivary gland tumors of Lung and Tracheobronchial Tree.

C. Pramesh, V. Noronha, N. Purandare, 2024, Annals of diagnostic pathology.

Imaging Recommendations for Diagnosis, Staging, and Management of Bone Tumors

A. Puri, A. Gulia, N. Shetty, 2023, Indian Journal of Medical and Paediatric Oncology.

High Response Rates and Promising Outcomes of Patients with Relapsed Ewing Sarcoma, Especially in Adolescents and Young Adults Treated on a Novel Hybrid Salvage Chemotherapy Regimen.

A. Puri, B. Rekhi, A. Gulia, 2020, Journal of adolescent and young adult oncology.

Clinical outcomes of ROS1-positive non-small cell lung cancer with limited access to ROS1-tyrosine kinase inhibitors (TKIs): experience from an Indian tertiary referral centre

V. Noronha, V. Patil, N. Purandare, 2024, Ecancermedicalscience.

Efficacy and Safety of Low-Dose Nivolumab in Treatment of Advanced Solid Tumors: A Retrospective Audit from Resource-Constrained Settings

V. Noronha, V. Patil, V. Talreja, 2024, South Asian Journal of Cancer.